question - What are the challenges in measuring the impact of health and wellbeing

initiatives? (500 words)

An auditor employed by a pharmaceutical company submits documentation to the FDA to support approval of new drugs. He suspected inaccuracies in the information he provided for one particular drug, and discovered that the project director had in fact falsified data When he reported this to his superiors, the company board of directors offered the auditor a deal. If he would not interfere with the FDA's imminent decision to approve the drug, the company would discontinue the drug and request the FDA to withdraw approval due to "mistakes in marketing projections." The aim was to avoid the bad press that would result from public knowledge of the falsification. The auditor accepted the deal, the company kept its word, and the project director quietly resigned. No further scandals of this sort have occurred, but the company made it harder for the auditor to investigate possible cover-ups